Annual Short Term Debt
$168.23 M
+$19.71 M+13.27%
March 31, 2024
Summary
- As of February 6, 2025, RDY annual short term debt is $168.23 million, with the most recent change of +$19.71 million (+13.27%) on March 31, 2024.
- During the last 3 years, RDY annual short term debt has fallen by -$158.65 million (-48.53%).
- RDY annual short term debt is now -75.05% below its all-time high of $674.41 million, reached on March 31, 2017.
Performance
RDY Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$507.15 M
+$15.27 M+3.10%
December 31, 2024
Summary
- As of February 6, 2025, RDY quarterly short term debt is $507.15 million, with the most recent change of +$15.27 million (+3.10%) on December 31, 2024.
- Over the past year, RDY quarterly short term debt has increased by +$214.21 million (+73.13%).
- RDY quarterly short term debt is now -34.10% below its all-time high of $769.59 million, reached on December 31, 2016.
Performance
RDY Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
RDY Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.3% | +73.1% |
| 3 y3 years | -48.5% | +73.1% |
| 5 y5 years | -28.7% | +140.7% |
RDY Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | +13.3% | at high | +487.2% |
| 5 y | 5-year | -54.6% | +13.3% | at high | +487.2% |
| alltime | all time | -75.0% | +7662.7% | -34.1% | >+9999.0% |
Dr Reddys Laboratories Limited Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $507.15 M(+3.1%) |
| Sep 2024 | - | $491.88 M(+67.9%) |
| Jun 2024 | - | $292.94 M(+74.1%) |
| Mar 2024 | $168.23 M(+13.3%) | $168.23 M(+2.5%) |
| Dec 2023 | - | $164.10 M(+90.0%) |
| Sep 2023 | - | $86.37 M(-6.6%) |
| Jun 2023 | - | $92.48 M(-37.7%) |
| Mar 2023 | $148.52 M(-59.9%) | $148.52 M(-24.2%) |
| Dec 2022 | - | $195.82 M(+3.0%) |
| Sep 2022 | - | $190.16 M(-34.1%) |
| Jun 2022 | - | $288.50 M(-22.1%) |
| Mar 2022 | $370.57 M(+13.4%) | $370.57 M(+24.6%) |
| Dec 2021 | - | $297.33 M(-9.0%) |
| Sep 2021 | - | $326.90 M(-10.7%) |
| Jun 2021 | - | $366.23 M(+12.0%) |
| Mar 2021 | $326.88 M(+18.5%) | $326.88 M(+72.3%) |
| Dec 2020 | - | $189.72 M(-32.3%) |
| Sep 2020 | - | $280.31 M(-14.4%) |
| Jun 2020 | - | $327.32 M(+18.7%) |
| Mar 2020 | $275.76 M(+16.9%) | $275.76 M(+30.9%) |
| Dec 2019 | - | $210.66 M(-8.6%) |
| Sep 2019 | - | $230.60 M(-9.8%) |
| Jun 2019 | - | $255.71 M(+8.4%) |
| Mar 2019 | $235.87 M(-40.1%) | $235.87 M(-13.8%) |
| Dec 2018 | - | $273.59 M(-28.9%) |
| Sep 2018 | - | $385.06 M(-5.9%) |
| Jun 2018 | - | $409.40 M(+4.0%) |
| Mar 2018 | $393.60 M(-41.6%) | $393.60 M(-17.5%) |
| Dec 2017 | - | $476.85 M(+8.5%) |
| Sep 2017 | - | $439.34 M(+9.9%) |
| Jun 2017 | - | $399.67 M(-40.7%) |
| Mar 2017 | $674.41 M(+96.2%) | $674.41 M(-12.4%) |
| Dec 2016 | - | $769.59 M(+3.3%) |
| Sep 2016 | - | $745.05 M(+87.6%) |
| Jun 2016 | - | $397.22 M(+15.5%) |
| Mar 2016 | $343.79 M(-25.4%) | $343.79 M(-1.1%) |
| Dec 2015 | - | $347.54 M(-13.4%) |
| Sep 2015 | - | $401.11 M(-12.8%) |
| Jun 2015 | - | $459.98 M(-0.2%) |
| Mar 2015 | $460.82 M(+14.9%) | $460.82 M(+25.8%) |
| Dec 2014 | - | $366.26 M(+7.6%) |
| Sep 2014 | - | $340.52 M(-9.6%) |
| Jun 2014 | - | $376.52 M(-6.1%) |
| Mar 2014 | $401.07 M(-9.6%) | $401.07 M(-5.9%) |
| Dec 2013 | - | $426.36 M(+11.2%) |
| Sep 2013 | - | $383.43 M(-23.4%) |
| Jun 2013 | - | $500.82 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | $443.60 M(+43.5%) | $443.60 M(+24.6%) |
| Dec 2012 | - | $356.11 M(+4.4%) |
| Sep 2012 | - | $340.95 M(+7.4%) |
| Jun 2012 | - | $317.36 M(+2.7%) |
| Mar 2012 | $309.09 M(-24.6%) | $309.09 M(-24.4%) |
| Dec 2011 | - | $408.88 M(-23.1%) |
| Sep 2011 | - | $531.88 M(+27.8%) |
| Jun 2011 | - | $416.17 M(+1.5%) |
| Mar 2011 | $409.94 M(+97.5%) | $409.94 M(+35.4%) |
| Dec 2010 | - | $302.72 M(+11.7%) |
| Sep 2010 | - | $270.93 M(+30.5%) |
| Jun 2010 | - | $207.58 M(+0.0%) |
| Mar 2010 | $207.52 M(+9.9%) | $207.52 M(+69.0%) |
| Dec 2009 | - | $122.82 M(-7.0%) |
| Sep 2009 | - | $132.11 M(-30.0%) |
| Mar 2009 | $188.80 M(+13.8%) | $188.80 M(-17.6%) |
| Dec 2008 | - | $229.25 M(+4.3%) |
| Sep 2008 | - | $219.84 M(+57.4%) |
| Jun 2008 | - | $139.72 M(-15.8%) |
| Mar 2008 | $165.88 M(+3.5%) | $165.88 M(+32.9%) |
| Dec 2007 | - | $124.86 M(+22.5%) |
| Sep 2007 | - | $101.90 M(+41.5%) |
| Jun 2007 | - | $71.99 M(-55.1%) |
| Mar 2007 | $160.28 M(-29.2%) | $160.28 M(-43.8%) |
| Dec 2006 | - | $285.24 M(+11.3%) |
| Sep 2006 | - | $256.22 M(+1.3%) |
| Jun 2006 | - | $252.89 M(+11.7%) |
| Mar 2006 | $226.47 M(+252.4%) | $226.47 M(+165.4%) |
| Dec 2005 | - | $85.33 M(-8.9%) |
| Sep 2005 | - | $93.69 M(+3.8%) |
| Jun 2005 | - | $90.29 M(+40.5%) |
| Mar 2005 | $64.26 M(+487.1%) | $64.26 M(+37.7%) |
| Dec 2004 | - | $46.67 M(+48.6%) |
| Sep 2004 | - | $31.40 M(-38.5%) |
| Jun 2004 | - | $51.09 M(+366.8%) |
| Mar 2004 | $10.94 M(+83.0%) | $10.94 M(+221.8%) |
| Dec 2003 | - | $3.40 M(+5.6%) |
| Sep 2003 | - | $3.22 M(+0.7%) |
| Jun 2003 | - | $3.20 M(-46.5%) |
| Mar 2003 | $5.98 M(+176.0%) | $5.98 M(+4720.0%) |
| Dec 2002 | - | $124.10 K(+1.0%) |
| Sep 2002 | - | $122.90 K(-25.1%) |
| Jun 2002 | - | $164.00 K(-92.4%) |
| Mar 2002 | $2.17 M(-96.6%) | $2.17 M(-31.3%) |
| Dec 2001 | - | $3.15 M(-52.2%) |
| Sep 2001 | - | $6.59 M(-36.2%) |
| Jun 2001 | - | $10.32 M |
| Mar 2001 | $63.56 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual short term debt?
- What is the all time high annual short term debt for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual short term debt year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly short term debt?
- What is the all time high quarterly short term debt for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly short term debt year-on-year change?
What is Dr Reddys Laboratories Limited annual short term debt?
The current annual short term debt of RDY is $168.23 M
What is the all time high annual short term debt for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual short term debt is $674.41 M
What is Dr Reddys Laboratories Limited annual short term debt year-on-year change?
Over the past year, RDY annual short term debt has changed by +$19.71 M (+13.27%)
What is Dr Reddys Laboratories Limited quarterly short term debt?
The current quarterly short term debt of RDY is $507.15 M
What is the all time high quarterly short term debt for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly short term debt is $769.59 M
What is Dr Reddys Laboratories Limited quarterly short term debt year-on-year change?
Over the past year, RDY quarterly short term debt has changed by +$214.21 M (+73.13%)